RxDoctor Payments Data

Raymond Chaloka, MD

Urology · Bayamon, PRNPI 1265434971

Payments from drug & device makers

What this record shows

11 manufacturers reported payments, led by Procept Biorobotics Corporation at 32.8% of the total.

$3,613in general payments, 2019–2025

Across 29 payments — averaging $124.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Procept Biorobotics Corporation$1K
  • Olympus Corporation Of The Americas$838
  • Teleflex LLC$748
  • Olympus Latin America, Inc.$199
  • Verity Pharmaceuticals Inc.$150
  • Boston Scientific$125
  • plus $369 from 5 others

What the payments were for

  • Travel & lodging$1,90253%
  • Food & beverage$1,71147%

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Procept Biorobotics Corporation4$1,185
Olympus Corporation Of The Americas4$838
Teleflex LLC10$748
Olympus Latin America, Inc.2$199
Verity Pharmaceuticals Inc.2$150
Boston Scientific2$125
AbbVie1$100
Johnson & Johnson1$100
Merck1$100
Neotract Inc.1$47
Johnson And Johnson International1$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,613 in reported general payments places this provider in the 65th percentile of 122 urology providers in Puerto Rico.

See all urology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$36,858
Medicare patients
43
Services billed
234

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron50$32,679
Tamsulosin Hcl1,220$15,427
Finasteride488$10,214
Alfuzosin Hcl ErAlfuzosin Hcl217$4,575
Silodosin75$4,382
Tolterodine Tartrate ErTolterodine Tartrate46$3,184
CefuroximeCefuroxime Axetil125$2,432
Ciprofloxacin Hcl327$929
Bicalutamide31$861
Diclofenac Potassium71$850
Levofloxacin84$760
Sildenafil Citrate57$512
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav19$493
Oxybutynin Chloride ErOxybutynin Chloride29$482
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst21$391

Paid to pharmacies, not to this prescriber.

Other urology in Bayamon

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →